| Literature DB >> 25750691 |
Adefolakemi Babatunde1, Asim Rizvi2, Quynh A Truong2.
Abstract
Acute chest pain remains one of the most common patient presentations encountered in the emergency department. With the evolution of biomarkers and improvement in cardiac imaging there has been advancement in risk stratification of patients, but millions of dollars continue to be spent in the assessment of chest pain. Investigators have explored possible comparative alternatives to the traditional work up of chest pain. In this review, we will discuss the current state of biomarker use in the evaluation of acute chest pain. We will review established and emerging circulating biomarkers and their addition to cardiac CT for appropriate diagnosis of coronary artery disease.Entities:
Year: 2014 PMID: 25750691 PMCID: PMC4350662 DOI: 10.1007/s12410-014-9277-x
Source DB: PubMed Journal: Curr Cardiovasc Imaging Rep ISSN: 1941-9074